FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

466211000001101: Antabuse 200mg tablets (Alpharma Limited) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17084501000001115 Antabuse 200mg tablets (Alpharma Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37777301000001113 Antabuse 200mg tablets (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antabuse 200mg tablets (Alpharma Limited) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Is a Product containing precisely disulfiram 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Has excipient Lactose false Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Has active ingredient Central nervous system agent false Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Has active ingredient Disulfiram false Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Is a Antabuse true Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Has specific active ingredient Disulfiram true Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Antabuse 200mg tablets (Alpharma Limited) 50 tablet Is pack of False Antabuse 200mg tablets (Alpharma Limited) Inferred relationship Existential restriction modifier
Antabuse 200mg tablets (Alpharma Limited) 50 tablet Has AMP True Antabuse 200mg tablets (Alpharma Limited) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start